Inhibrx Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Inhibrx Biosciences has a total shareholder equity of $219.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $258.4M and $39.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$226.86m |
Equity | US$219.37m |
Total liabilities | US$39.05m |
Total assets | US$258.42m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INBX's short term assets ($242.1M) exceed its short term liabilities ($39.1M).
Long Term Liabilities: INBX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: INBX is debt free.
Reducing Debt: INBX has not had any debt for past 5 years.
Debt Coverage: INBX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: INBX has no debt, therefore coverage of interest payments is not a concern.